Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen treatments can help with various women's health issues but often require ongoing use.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Certain gene variations and irregular X chromosome activity may contribute to hair loss in women who can have children.

Androgenetic alopecia causes hair loss, affects men more severely, and treatments are only temporarily effective.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Testosterone stimulates growth in intermediate hair follicles, but this can be blocked by cyproterone acetate.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

An ovarian tumor can cause high male hormones in postmenopausal women.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

A new method effectively predicts estrogen-related health effects for early screening.

Estrogen helps promote hair growth in women with androgenetic alopecia.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

We need better ways to test and understand SARMs to make safer and more effective treatments.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.